What the company does
Classys makes medical devices used in aesthetic clinics to tighten skin and reshape facial contours without surgery, using energy-based technologies such as focused ultrasound, radiofrequency, microneedle radiofrequency, and laser.
Its devices and the consumables required to operate them are supplied to clinics, hospitals, and distributors across more than eighty countries worldwide. Listed on KOSDAQ, Korea's tech-focused stock exchange, the company's portfolio spans its Ultraformer, Volnewmer, Everesse, Quadessy, and reepot device lines, covering the main categories of energy-based aesthetic treatment.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$130.5M
- FY2024US$176M
- FY2025US$244.1M
Operating profit
- FY2023US$64.9M
- FY2024US$88.7M
- FY2025US$123.6M
Net income
- FY2023US$53.8M
- FY2024US$70.7M
- FY2025US$95.6M
Key ratios (FY2025)
Why it matters · Context, not a recommendation
Alongside device sales, consumables, single-use items required each time a machine is operated, form a distinct and recurring revenue category as the installed base of devices grows.
Filings
All disclosures · English when translatedPrice charts coming soon
Interactive price history isn't here yet. Would you use it?